A Comparison of Single- and Multiparametric MRI Models for Differentiation of Recurrent Glioblastoma from Treatment-Related Change.
apparent diffusion coefficient
cerebral radiation necrosis
dynamic susceptibility contrast perfusion imaging
glioblastoma
multivariate logistic regression
pseudoprogression
treatment-related changes
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
06 Dec 2021
06 Dec 2021
Historique:
received:
27
10
2021
revised:
24
11
2021
accepted:
03
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
To evaluate single- and multiparametric MRI models to differentiate recurrent glioblastoma (GBM) and treatment-related changes (TRC) in clinical routine imaging. Selective and unselective apparent diffusion coefficient (ADC) and minimum, mean, and maximum cerebral blood volume (CBV) measurements in the lesion were performed. Minimum, mean, and maximum ratios
Identifiants
pubmed: 34943518
pii: diagnostics11122281
doi: 10.3390/diagnostics11122281
pmc: PMC8700236
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurooncol. 2020 Nov;150(2):95-120
pubmed: 33215340
Lancet Oncol. 2015 Nov;16(15):e534-e542
pubmed: 26545842
Neuro Oncol. 2019 Feb 19;21(3):404-414
pubmed: 30107606
AJNR Am J Neuroradiol. 2016 Jan;37(1):28-36
pubmed: 26450533
Radiol Clin North Am. 2019 Nov;57(6):1199-1216
pubmed: 31582045
J Neurosurg Sci. 2019 Dec;63(6):688-696
pubmed: 31961118
AJNR Am J Neuroradiol. 2011 Feb;32(2):382-7
pubmed: 21252041
Pharmacol Ther. 2015 Aug;152:63-82
pubmed: 25944528
AJNR Am J Neuroradiol. 2015 May;36(5):877-85
pubmed: 25593202
Oncology (Williston Park). 2019 Mar 13;33(3):91-100
pubmed: 30866031
Radiol Med. 2014 Aug;119(8):616-24
pubmed: 24408041
Contrast Media Mol Imaging. 2018 Dec 2;2018:6828396
pubmed: 30627060
AJNR Am J Neuroradiol. 2014 Jul;35(7):1309-17
pubmed: 24676005
Cancers (Basel). 2020 Apr 10;12(4):
pubmed: 32290213
J Neurooncol. 2017 Sep;134(3):495-504
pubmed: 28382534
Curr Med Chem. 2019;26(31):5862-5874
pubmed: 29768997
Acta Neurochir (Wien). 2012 Feb;154(2):191-201; discussion 201
pubmed: 22130634
CA Cancer J Clin. 2020 Jul;70(4):299-312
pubmed: 32478924
Radiology. 1988 Mar;166(3):823-7
pubmed: 2829270
Clin Cancer Res. 2013 Feb 15;19(4):764-72
pubmed: 23209033
Nat Commun. 2019 Jul 18;10(1):3170
pubmed: 31320621
Int J Mol Sci. 2014 Jul 03;15(7):11832-46
pubmed: 24995696
Eur Radiol. 2018 Aug;28(8):3306-3317
pubmed: 29536240
Front Neurol. 2018 Jan 22;8:660
pubmed: 29403420
Eur Radiol. 2017 Oct;27(10):4129-4144
pubmed: 28332014
Neuro Oncol. 2017 Jan;19(1):118-127
pubmed: 27502247
J Neurooncol. 2020 Jun;148(2):373-379
pubmed: 32409944
J Clin Oncol. 2017 Jul 20;35(21):2402-2409
pubmed: 28640706
Cancer. 2020 Jun 1;126(11):2625-2636
pubmed: 32129893
Cancers (Basel). 2020 Mar 19;12(3):
pubmed: 32204544
AJNR Am J Neuroradiol. 2011 Dec;32(11):1978-85
pubmed: 21393407
Cancers (Basel). 2020 Oct 08;12(10):
pubmed: 33049911
Korean J Radiol. 2013 Jul-Aug;14(4):662-72
pubmed: 23901325
AJNR Am J Neuroradiol. 2018 Dec;39(12):2187-2193
pubmed: 30385468
Chin J Cancer. 2014 Jan;33(1):16-24
pubmed: 24384237
Neuro Oncol. 2018 Oct 9;20(11):1429-1438
pubmed: 29509936
Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8
pubmed: 27668386
Int J Mol Sci. 2020 Mar 12;21(6):
pubmed: 32178267
Clin Transl Oncol. 2018 Jan;20(1):22-28
pubmed: 29086250
Cancers (Basel). 2020 Feb 29;12(3):
pubmed: 32121471
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
JAMA Oncol. 2016 Nov 1;2(11):1460-1469
pubmed: 27310651
Chin Clin Oncol. 2017 Aug;6(4):40
pubmed: 28841802